Skip to content

Multiple Myeloma Update From the 2014 ASH Annual Meeting

Program Evaluation

Program Objective:
To provide the latest data that was presented at the 2014 American Society of Hematology (ASH) Annual Meeting.
1.Please take a few moments to rate this program and the speakers. (Required.)
Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
The program met its stated objective (listed above)
The level of material presented was appropriate
The program was easy to access
I will participate in future MMRF-sponsored programs
2.How did you learn about this program? (Indicate all that apply)(Required.)
3.What influenced your decision to attend our program? (Indicate all that apply)(Required.)
4.What is your preferred method to receive myeloma information? (Indicate all that apply) (Required.)
5.Please rate the quality of the faculty presentations on a scale of 1 (Poor) to 5 (Excellent).(Required.)
Content
Relevance
Smoldering Multiple Myeloma
Upfront Therapy
Stem Cell Transplantation
Maintenance Therapy
Relapsed/Refractory Disease
Disease Complications and Side Effects
Predictive/Prognostic Markers and Personalized Medicine
6.I am a...(Required.)
7.Will the information presented today help influence you to modify or change any aspect of your treatment decisions? (Required.)
8.What topics would you like to see presented in future myeloma-specific programs?
9.Additional comments
10.Name (Optional)
11.Email (Optional)
Your input will help us to further develop patient education programs that address the needs of the myeloma community. Thank you for your participation.
* Indicates Response Required
Privacy & Cookie Notice